{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:58:58Z","timestamp":1649073538956},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Echocardiogr"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12574-020-00484-8","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T12:04:39Z","timestamp":1596715479000},"page":"45-52","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Three cases of late-onset anthracycline-related cardiomyopathy due to chemotherapies for hematological malignancy"],"prefix":"10.1007","volume":"19","author":[{"given":"Noriaki","family":"Kawano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Tochigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakaike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenobu","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Mashiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"484_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, et al. Non-Hodgkin lymphoma. Lancet. 2017;390:298\u2013310.","journal-title":"Lancet"},{"key":"484_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000265166","volume":"115","author":"K Chatterjee","year":"2010","unstructured":"Chatterjee K, Zhang J, Honbo N, et al. Doxorubicin cardiomyopathy. Cardiology. 2010;115:155\u201362.","journal-title":"Cardiology"},{"key":"484_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jacep.2016.08.009","volume":"3","author":"M Mazur","year":"2017","unstructured":"Mazur M, Wang F, Hodge DO, et al. Burden of cardiac arrhythmias in patients\u00a0with anthracycline-related cardiomyopathy. JACC Clin Electrophysiol. 2017;3:139\u201350.","journal-title":"JACC Clin Electrophysiol"},{"key":"484_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.carpath.2009.07.004","volume":"19","author":"BN Bernaba","year":"2010","unstructured":"Bernaba BN, Chan JB, Lai CK, et al. Pathology of late-onset anthracycline cardiomyopathy. Cardiovasc Pathol. 2010;19:308\u201311.","journal-title":"Cardiovasc Pathol"},{"key":"484_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2165\/00002018-200629070-00003","volume":"29","author":"L Sl\u00f8rdal","year":"2006","unstructured":"Sl\u00f8rdal L, Spigset O. Heart failure induced by non-cardiac drugs. Drug Saf. 2006;29:567\u201386.","journal-title":"Drug Saf"},{"key":"484_CR6","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, et al. ESC Scientific Document Group 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: & #x2002;The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2768\u2013801.","journal-title":"Eur Heart J"},{"key":"484_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cjca.2016.01.028","volume":"32","author":"H Abdel-Qadir","year":"2016","unstructured":"Abdel-Qadir H, Amir E, Thavendiranathan P. Prevention, detection, and management of chemotherapy-related cardiac dysfunction. Can J Cardiol. 2016;32:891\u20139.","journal-title":"Can J Cardiol"},{"key":"484_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15420\/ecr.2015.10.01.19","volume":"10","author":"SE Piper","year":"2015","unstructured":"Piper SE, McDonagh TA. Chemotherapy-related cardiomyopathy. Eur Cardiol. 2015;10:19\u201324.","journal-title":"Eur Cardiol"},{"key":"484_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","volume":"27","author":"JC Plana","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27:911\u201339.","journal-title":"J Am Soc Echocardiogr"},{"key":"484_CR10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","volume":"15","author":"JC Plana","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15:1063\u201393.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"484_CR11","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131:1981\u20138.","journal-title":"Circulation"},{"key":"484_CR12","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1001\/jama.1991.03470120074036","volume":"266","author":"LJ Steinherz","year":"1991","unstructured":"Steinherz LJ, Steinherz PG, Tan CT, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991;266:1672\u20137.","journal-title":"JAMA"}],"container-title":["Journal of Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12574-020-00484-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12574-020-00484-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12574-020-00484-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T23:16:12Z","timestamp":1628205372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12574-020-00484-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1007\/s12574-020-00484-8","relation":{},"ISSN":["1349-0222","1880-344X"],"issn-type":[{"value":"1349-0222","type":"print"},{"value":"1880-344X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Noriaki Kawano, Sayaka Kawano, Shuro Yoshida, Takuro Kuriyama, Taro Tochigi, Takashi Nakaike, Tomonori Shimokawa, Kiyoshi Yamashita, Hidenobu Ochiai, Kazuya Shimoda, Koichi Mashiba and Ikuo Kikuchi declare that they have no conflict of interest (COI).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions. Informed consent was obtained from all patients for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights statements and informed consent"}}]}}